Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2014
10/16/2014US20140309161 Modified antibiotic peptides having variable systemic release
10/16/2014US20140308380 Milk yield and/or milk quality improving agent, perinatal disease preventive or therapeutic agent, and reproductivity improving agent for ruminant
10/16/2014US20140308374 Formulations of Concentrated Prunes and Prebiotics as Laxatives and Dietary Supplements
10/16/2014US20140308368 Ophthalmological aqueous composition
10/16/2014US20140308365 Pharmaceutical composition useful for adhesion prevention or hemostasis
10/16/2014US20140308360 Nanoparticles and nanoparticle compositions
10/16/2014US20140308357 Melatonin-based solutions and powders for their preparation
10/16/2014US20140308354 Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
10/16/2014US20140308351 Method of Forming Non-Immunogenic Hydrophobic Protein Nanoparticles, and Uses Therefor
10/16/2014US20140308343 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
10/16/2014US20140308341 Methods and compositions for liposomal formulation of antigens and uses thereof
10/16/2014US20140308331 Interpolymer network delivery system
10/16/2014US20140308326 Antimicrobial compositions of aminoglycosidic antibiotics and zinc ion chelators specifically formulated for enhanced inhibition of bacterial colonization and antibacterial efficacy
10/16/2014US20140308318 Inhibitors against Endosomal/Lysosomal Enzymes
10/16/2014US20140308311 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine
10/16/2014US20140308304 Lipids for the delivery of active agents
10/16/2014US20140308302 Anti-5t4 antibodies and uses thereof
10/16/2014US20140308281 Antibodies directed against the alpha chain of il7 receptor - their use for the preparation of drug candidates
10/16/2014US20140308278 Class I Anti-CEA Antibodies and Uses Thereof
10/16/2014US20140308271 Antibodies that bind to tl1a and their uses
10/16/2014US20140308270 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
10/16/2014US20140308239 Chimeric cytokine formulations for ocular delivery
10/16/2014US20140308238 Immunomodulating compositions and methods of use thereof
10/16/2014US20140308235 METAP2 Inhibitors and Methods of Treating Obesity
10/16/2014US20140308234 Drug delivery polymer and uses thereof
10/16/2014US20140308233 Ndga polymers and metal complexes thereof
10/16/2014US20140308223 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
10/16/2014US20140308212 Edible plant-derived microvesicle compositions for diagnosis and treatment of disease
10/16/2014US20140308209 Soluble Mediator
10/16/2014US20140308208 Caged compound delivery and related compositions, methods and systems
10/16/2014US20140308205 Trifunctional and completely clearable specific targeting agents and methods thereof
10/16/2014US20140308203 Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors
10/16/2014US20140308201 Antibody drug conjugates
10/14/2014USRE45198 Omeprazole solution and method for using same
10/14/2014US8859807 Glutathione preparation and method for production thereof
10/14/2014US8859731 Selective modification of proteins
10/14/2014US8859728 Peptides that target dorsal root ganglion neurons
10/14/2014US8859727 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
10/14/2014US8859706 Bioactive hydrogel
10/14/2014US8859705 Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
10/14/2014US8859629 Fused cyclooctyne compounds and their use in metal-free click reactions
10/14/2014US8859624 Stable rasagiline composition
10/14/2014US8859619 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
10/14/2014US8859603 Method for solubilizing metronidazole
10/14/2014US8859554 Packaging assembly for pharmaceutical composition including pimobendan
10/14/2014US8859527 Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof
10/14/2014US8859525 Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
10/14/2014US8859523 Crosslinked compounds and methods of making and using thereof
10/14/2014US8859509 Chimeric small molecules for the recruitment of antibodies to cancer cells
10/14/2014US8859507 Protein complex for intracellular delivery and uses thereof
10/14/2014US8859506 Glycopeptide phosphonate derivatives
10/14/2014US8859499 Method of enhancing efficacy of blood transfusions
10/14/2014US8859498 Targeted therapeutic proteins
10/14/2014US8859497 Method of treatment using cysteine mutants of beta interferon
10/14/2014US8859493 Insulin derivatives
10/14/2014US8859492 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
10/14/2014US8859284 Delivery of nanoparticles to neurons
10/14/2014US8859274 Antibody fragment-targeted immunoliposomes for systemic gene delivery
10/14/2014US8859001 Fenoldopam formulations and pro-drug derivatives
10/14/2014US8858997 Formulations and methods for lyophilization and lyophilates provided thereby
10/14/2014US8858995 Methods and compositions for controlled delivery of phytochemical agents
10/14/2014US8858972 Antimicrobial medicotechnical product, process for its preparation and use
10/14/2014US8858967 Dermatological cream-gels containing avermectin compounds
10/14/2014US8858962 Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration
10/14/2014US8858961 Compositions containing alpha-2-adrenergic agonist components
10/14/2014US8858955 Process for manufacturing vaccines
10/14/2014US8858950 Delivery of pharmaceutical agents via the human insulin receptor
10/14/2014US8858927 Method for protection of peptides or proteins against non-enzymatic deamidation
10/14/2014US8858925 Pegylated fibrinogen precursor molecule
10/14/2014US8858924 Compositions and methods for treatment of hemorrhage
10/14/2014US8858917 Methods for limiting spread of pulmonary infections
10/09/2014WO2014165617A1 Mesoporous alum nanoparticles as universal platform for antigen adsorption, presentation, and delivery
10/09/2014WO2014165566A1 Hydrophilic particle compositions, processes of production, and uses in dietary management and digestive disorders
10/09/2014WO2014165246A1 Coprocessed silica coated polymer composition
10/09/2014WO2014165241A1 Coprocessed silica coated polymer composition
10/09/2014WO2014165239A1 Chelation suppository for improved drug delivery
10/09/2014WO2014165108A1 Bioerodible silicon-based delivery vehicles for delivery of therapeutic agents
10/09/2014WO2014165093A2 Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
10/09/2014WO2014164957A1 Nanoparticulate and macroparticulate formulations
10/09/2014WO2014164712A1 Formation and uses of europium
10/09/2014WO2014163558A1 Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
10/09/2014WO2014163513A1 Therapeutic compositions and uses thereof
10/09/2014WO2014163492A1 Composition as auxiliary means for oral medication
10/09/2014WO2014163222A1 Metal oxide nanoparticle-based magnetic resonance imaging contrast agent with a central cavity
10/09/2014WO2014163221A1 Metal oxide nanoparticle-based t1-t2 dual-mode magnetic resonance imaging contrast agent
10/09/2014WO2014163150A1 Composition for internal use
10/09/2014WO2014163132A1 Solid composition of amino carboxylate salt
10/09/2014WO2014163092A1 Drug coat layer, method for controlling morphological form of drug coat layer, and medical device
10/09/2014WO2014162930A1 Oil-in-water emulsion composition
10/09/2014WO2014162906A1 (sugar chain)-polypeptide complex
10/09/2014WO2014162515A1 Peritoneal dialysis fluid
10/09/2014WO2014161926A1 Supramolecular aggregates comprising maleimido cores
10/09/2014WO2014161836A1 Treatment of metabolic disorders in equine animals
10/09/2014WO2014161815A1 Glycogen-based water solubility enhancers
10/09/2014WO2014161284A1 Cell-penetrating polypeptides and uses thereof in drug delivery
10/09/2014WO2014161131A1 PREPARING AMORPHOUS MELOXICAM-β-CYCLODEXTRIN INCLUSION COMPLEX VIA SPRAY DRYING PROCESS
10/09/2014WO2014161085A1 Schiff-based aldehydic hyaluronic acid-chitosan hydrogel compositions and uses thereof
10/09/2014WO2014161031A1 Nanoparticles for drug delivery comprising albumin having a polymer chain coupled thereto
10/09/2014US20140303590 Method and composition for hyperthermally treating cells
10/09/2014US20140303571 Titratable dosage transdermal delivery system
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 1712